High Rate of Symptoms Reported Post Gastric Bypass Procedure

This article originally appeared here.
Share this content:
High Rate of Symptoms Reported Post Gastric Bypass Procedure
High Rate of Symptoms Reported Post Gastric Bypass Procedure

WEDNESDAY, Jan. 6, 2016 (HealthDay News) -- While most patients who undergo Roux-en-Y gastric bypass surgery say their well-being has improved, high rates of symptoms and hospitalization are also reported, according to a study published online Jan. 6 in JAMA Surgery.

Surveys completed by 1,429 people in Denmark who underwent Roux-en-Y surgery between 2006 and 2011 showed that 87.4 percent reported that their well-being was improved after versus before surgery. Another 7 percent reported reduced well-being after their procedure. Nearly 89 percent of patients reported one or more side effects such as abdominal pain and fatigue a median of 4.7 years after surgery, and 29.1 percent of patients were hospitalized.

Nearly 68 percent of the patients sought health care due to their symptoms. The most common reasons for seeking health care were abdominal pain (34.2 percent), fatigue (34.1 percent), and anemia (27.7 percent). Patients most likely to have symptoms after surgery were women, smokers, those younger than 35, those who were unemployed, and those with symptoms before surgery. The more symptoms patients had, the lower their quality of life.

"Focus on the quality of life among patients with many symptoms may be required since such patients are at risk of depression," study leader Sigrid Bjerge Gribsholt, M.D., from the Aarhus University Hospital in Denmark, and colleagues write. "Development of new weight-loss treatments with less risk of subsequent symptoms should be a high priority."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »